Feed Top Reports Pricing

⌘K

17:40:17·44d

INSIDERFiling

SEC Form 4 filed by Kyntra Bio Inc.

KYNB· Kyntra Bio Inc.

Health Care

Full content unavailable. See the original source below.

Original source

Companies

KYNB
Kyntra Bio Inc.
Health Care

Related

SEC14d
Kyntra Bio Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
PR15d
Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference
SEC38d
SEC Form 10-K filed by Kyntra Bio Inc.
SEC38d
Kyntra Bio Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
PR38d
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
INSIDER44d
SEC Form 4 filed by Kyntra Bio Inc.
PR45d
Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results
PR59d
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022